NGlycolylGM3/VSSP Vaccine in Metastatic Breast Cancer Patients: Results of Phase I/IIa Clinical Trial

Patients treated with vaccines based on NGlycolil gangliosides have showed benefit in progression free survival and overall survival. These molecules, which have been observed in breast cancer cells, are minimally or not expressed in normal human tissue and have been considered as antigen tumor-spec...

Descripción completa

Detalles Bibliográficos
Autores principales: de la Torre, Ana, Hernandez, Julio, Ortiz, Ramón, Cepeda, Meylán, Perez, Kirenia, Car, Adriana, Viada, Carmen, Toledo, Darién, Guerra, Pedro Pablo, García, Elena, Arboláez, Migdacelys, Fernandez, Luis E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465086/
https://www.ncbi.nlm.nih.gov/pubmed/23055739
http://dx.doi.org/10.4137/BCBCR.S8488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465086/
https://www.ncbi.nlm.nih.gov/pubmed/23055739
http://dx.doi.org/10.4137/BCBCR.S8488

Ejemplares similares